U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911267) titled 'Development and Utilization of an Integrated Clinical Genomic Database' on Oct. 22.
Brief Summary: This observational study aims to develop an integrated genomic and clinical database to support the discovery and validation of biomarkers for cancer diagnosis, treatment selection, and prediction of treatment response.
The study will include adults aged 19 years or older with diagnosed or suspected cancer, as well as consenting individuals undergoing routine health screenings at Samsung Medical Center. Researchers will collect residual tissue specimens obtained during routine diagnostic or therapeutic procedures and additional blood s...